https://www.selleckchem.com/products/mdl-800.html
Patients with hepatitis B virus-associated acute-on-chronic liver failure (HBV-ACLF) present a complex and poor prognosis. Systemic inflammation plays an important role in its pathogenesis, and interleukin-6 (IL-6) as a pro-inflammatory cytokine is related with severe liver impairment and also plays a role in promoting liver regeneration. Whether serum IL-6 influences HBV-ACLF prognosis has not been studied. To determine the impact of serum IL-6 on outcome of patients with HBV-ACLF. We performed a retrospective study of 412 HBV-ACLF pat
Like
Comment
Share
